Our findings with glioblastoma and medulloblastoma cells differ from those in other studies where it was reported that elevating SOX2 enhances the growth and tumorigenicity of DU145 prostate tumor cells [19], MCF7 breast tumor cells [18] and A549 lung tumor cells [20]. This evidence concerns the gene SOX2 and prostate neoplasm.